Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Xifaxan

Rifaximin

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Xifaxan:

 BioPortfolio Logo
How can pharmaceutical companies best tap into the travel health market? 1st January, 1970 Datamonitor
How can pharmaceutical companies best tap into the travel health market? Recent events, such as the approval of Salix Pharmaceutical's oral antibiotic Xifaxan, suggest renewed interest in the

This page has been viewed 65 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Xifaxan across BioPortfolio, or for Xifaxan Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.